Commentary

Industry Faces Tough Road to Institutionalization of Key Premium, Eligibility Up for Discussion

Lexicon

Japan Medical Association (JMA):
日本医師会

The Column

Emerging Immunotherapy of Cancer: 2

Archives

Chuikyo Subcommittee OKs Point-Based Premium Calculation Method, Adoption Scheduled in May (Apr.24)
LDP Study Group to Call for Expansion of R&D Tax Credit System, Oppose Annual NHI Price Cuts (Apr.24)
MTPC Names Masayuki Mitsuka as New President (Apr.24)
JPMA Announces New Guidelines on Support for Clinical Research (Apr.24)
Yoshindo, Lupin to Establish JV to Develop Etanercept Biosimilar, Start Clinical Trial in FY2014 (Apr.24)

Most Read

1.
Sanofi Aims to ...
2.
New Health Mini...
3.
DPJ Member Naga...
3.
Entry into Japa...
5.
Blue Letter on ...

News Calendar